JMV 236: cholecystokinin antagonist [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 53462162 |
| MeSH ID | M0172532 |
| Synonym |
|---|
| jmv 236 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| thymidine | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |
| meglumine | hexosamine; secondary amino compound | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | ||
| ci 988 | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |||
| jmv 179 | 1994 | 1994 | 30.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |||
| devazepide | 1,4-benzodiazepinone; indolecarboxamide | antineoplastic agent; apoptosis inducer; cholecystokinin antagonist; gastrointestinal drug | 1996 | 2021 | 15.5 | medium | 0 | 0 | 1 | 0 | 0 | 1 | |
| l 365260 | benzodiazepine | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | ||
| sincalide | oligopeptide | 1990 | 2021 | 25.8 | high | 0 | 0 | 4 | 0 | 0 | 1 | ||
| cholecystokinin | 1990 | 2021 | 23.8 | high | 0 | 0 | 3 | 0 | 0 | 1 | |||
| gastrins | 1996 | 1996 | 28.0 | low | 0 | 0 | 1 | 0 | 0 | 0 | |||
| neuropeptide y | 1990 | 1990 | 34.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anaplastic Astrocytoma | 0 | 1996 | 1996 | 28.0 | high | 0 | 0 | 1 | 0 | 0 | 0 | |
| Astrocytoma | 0 | 1996 | 1996 | 28.0 | high | 0 | 0 | 1 | 0 | 0 | 0 | |
| Benign Neoplasms, Brain | 0 | 1996 | 1996 | 28.0 | high | 0 | 0 | 1 | 0 | 0 | 0 | |
| Brain Neoplasms | 0 | 1996 | 1996 | 28.0 | high | 0 | 0 | 1 | 0 | 0 | 0 |
| Article | Year |
|---|---|
| A cholecystokinin agonist/antagonist according to dose and time of action: effect on food intake. Neuropeptides, , Volume: 17, Issue:4 | 1990 |